Bakırkoy Dr. Sadi Konuk Training and Research Hospital Infectıous Diseases and Clinical Microbiology, Istanbul, Turkey.
Curr HIV Res. 2021;19(2):103-105. doi: 10.2174/1570162X18999201125212538.
In 2014, The Joint United Nations Program on HIV and AIDS (UNAIDS) has set an ambitious target code-named 90-90-90, which aims to ensure that 90% of all people living with HIV will know their state, 90% of all people diagnosed will receive sustained antiretroviral therapy, and 90% of all people receiving ART will have viral suppression by 2020. Since 2014, many tests and treatment programs have been developed to achieve the above goals worldwide. In 2019, it was reported that many developed countries can reach the target with the right strategies, as well as regions that are still far from the targets. It has been reported that the fourth 90 should be one of the targets related to HIV infection in recent years. This view, beyond virological suppression, was towards developing programs that would enable people living with HIV to live not only longer but also healthy. The socio-cultural and economic obstacles to reach the targets may vary according to geographical regions, but it is clear that COVID-19 disease, which has taken the whole world under the influence since 2019, is a major obstacle to the 90-90-90 targets worldwide. Difficulties in the diagnosis and access to ART and treatment nonadherence which may be encountered more frequently due to many factors may threaten both the health of people living with HIV and public health. The COVID-19 pandemic has disrupted many programs developed in the fight against the HIV epidemic. Considering COVID-19 disease and future epidemics that may create a chaotic environment, analyzing the difficulties experienced in the pandemic retrospectively, and determining new strategies that will bring appropriate solutions to the problems will play an important role in the proper management of future issues.
2014 年，联合国艾滋病规划署（UNAIDS）设定了一个名为“90-90-90”的宏伟目标，旨在确保到 2020 年，所有艾滋病毒感染者中 90%的人将知晓自身的感染状况，90%经诊断的人将接受持续的抗逆转录病毒治疗，90%接受抗逆转录病毒治疗的人将病毒得到抑制。自 2014 年以来，全世界已经开发了许多测试和治疗方案来实现上述目标。2019 年，据报道，许多发达国家可以通过正确的战略实现目标，而有些地区仍然远远落后于目标。据报道，第四个 90 应该是近年来与艾滋病毒感染相关的目标之一。这种观点不仅涉及病毒学抑制，还旨在制定方案，使艾滋病毒感染者不仅能活得更长，而且能更健康。达到目标的社会文化和经济障碍可能因地理位置而异，但很明显，自 2019 年以来，影响全球的 COVID-19 疾病是全球 90-90-90 目标的主要障碍。由于许多因素，诊断和获得抗逆转录病毒治疗以及治疗不依从的困难可能会更频繁地出现，这可能会威胁到艾滋病毒感染者的健康和公共卫生。COVID-19 大流行扰乱了许多防治艾滋病毒流行的方案。考虑到 COVID-19 疾病和未来可能造成混乱环境的传染病，回顾性分析大流行期间遇到的困难，并确定将为问题带来适当解决方案的新策略，将在适当管理未来问题方面发挥重要作用。
